|
Accuray (R) Incorporated, founded in 1990, develops radiosurgery systems that are used to treat cancer. The firm is known for its CyberKnife (R) Robotic Radiosurgery System, developed in 1987 at Stanford University Medical Center. The system supports the non-invasive treatment of tumors anywhere in the body. It originally was used to treat head, neck, and upper spine tumors. CyberKnife integrates image guidance and computer-controlled robotics components. It does not require the use of head or body frames. Accuray's Synchrony (R) Respiratory Tracking System, introduced in 2004, allows clinicians to detect, monitor, and treat tumors affected by respiration. Patients can breath normally throughout treatments. The Xsight (R) Spine Tracking System, introduced in 2005, automatically tracks tumors during treatments. It does not require the implantation of radiographic markers or fiducials. Accuray has deployed over 130 CyberKnife systems worldwide. The units have been used to treat over 40,000 patients. Accuray went public in 2007. The firm is listed on NASDAQ under the ARAY symbol. Accuray was founded by Dr. John R. Adler, formerly a professor of neurosurgery and radiation oncology at Stanford University Medical Center.
|
Information Sources, Inc.